申请人:Pfizer Inc.
公开号:US04309427A1
公开(公告)日:1982-01-05
Certain novel derivatives of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide have been prepared, including N-(2-pyridyl)-2-methyl-4-acetoxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, N-(2-pyridyl)-2-methyl-4-(n-butyryloxy)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, N-(6-methyl-2-pyridyl)-2-methyl-4-acetoxy-2H-1,2-benzothiazine-3-carboxami de 1,1-dioxide, N-(2-pyridyl)-2-methyl-4-benzoyloxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, N-(6-methyl-2-pyridyl)-2-methyl-4-benzoyloxy-2H-1,2-benzothiazine-3-carbox amide 1,1-dioxide, N-(2-pyridyl)-2-methyl-4-methanesulfonyloxy-2H-1,2-benzothiazine-3-carboxa mide 1,1-dioxide and N-(6-methyl-2-pyridyl)-2-methyl-4-methanesulfonyloxy-2H-1,2-benzothiazine- 3-carboxamide 1,1-dioxide. All these compounds are useful in therapy as non-steroidal anti-inflammatory agents, especially when administered by the topical route of administration. Methods for preparing these compounds from known starting materials are provided.
已经制备了N-(2-吡啶基)-2-甲基-4-羟基-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物的某些新颖衍生物,包括N-(2-吡啶基)-2-甲基-4-乙酰氧基-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物、N-(2-吡啶基)-2-甲基-4-(正丁酰氧基)-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物、N-(6-甲基-2-吡啶基)-2-甲基-4-乙酰氧基-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物、N-(2-吡啶基)-2-甲基-4-苯甲酰氧基-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物、N-(6-甲基-2-吡啶基)-2-甲基-4-苯甲酰氧基-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物、N-(2-吡啶基)-2-甲基-4-甲磺酰氧基-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物和N-(6-甲基-2-吡啶基)-2-甲基-4-甲磺酰氧基-2H-1,2-苯并噻嗪-3-羧酰胺1,1-二氧化物。所有这些化合物在治疗中作为非甾体类抗炎药物是有用的,特别是通过局部给药途径给予时。提供了从已知起始物质制备这些化合物的方法。